» Articles » PMID: 3894685

Monoclonal Antibodies Specific for Adenovirus Early Region 1A Proteins: Extensive Heterogeneity in Early Region 1A Products

Overview
Journal J Virol
Date 1985 Sep 1
PMID 3894685
Citations 225
Authors
Affiliations
Soon will be listed here.
Abstract

Hybridomas secreting monoclonal antibodies specific for the adenovirus early region 1A (E1A) proteins were prepared from BALB/c mice immunized with a bacterial trpE-E1A fusion protein. This protein is encoded by a hybrid gene that joins a portion of the Escherichia coli trpE gene and a cDNA copy of the E1A 13S mRNA (Spindler et al., J. Virol. 49:132-141, 1984). Eighty-three hybridomas that secrete antibodies which recognize the immunogen were isolated and single cell cloned. Twenty-nine of these antibodies are specific for the E1A portion of the fusion protein. Only 12 of the monoclonal antibodies can efficiently immunoprecipitate E1A polypeptides from detergent lysates of infected cells. E1A polypeptides were analyzed on one-dimensional, sodium dodecyl sulfate-polyacrylamide gels and two-dimensional, isoelectric focusing polyacrylamide gels. The E1A proteins that are specifically immunoprecipitated by the monoclonal antibodies are heterogeneous in size and charge and can be resolved into approximately 60 polypeptide species. This heterogeneity is due not only to synthesis from multiple E1A mRNAs, but also at least in part to post-translational modification. Several of the monoclonal antibodies divide the E1A polypeptides into immunological subclasses based on the ability of the antibodies to bind to the antigen. In particular, two of the monoclonal antibodies bind to the polypeptides synthesized from the 13S E1A mRNA, but not to other E1A proteins.

Citing Articles

Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler.

Cantarella S, Vezzoli M, Carnevali D, Morselli M, Zemke N, Montanini B Nucleic Acids Res. 2024; 52(16):9481-9500.

PMID: 39011896 PMC: 11381368. DOI: 10.1093/nar/gkae615.


Molecular insights into type I interferon suppression and enhanced pathogenicity by species B human adenoviruses B7 and B14.

Graves D, Akkerman N, Fulham L, Helwer R, Pelka P mBio. 2024; 15(8):e0103824.

PMID: 38940561 PMC: 11323573. DOI: 10.1128/mbio.01038-24.


Expanding the adenovirus toolbox: reporter viruses for studying the dynamics of human adenovirus replication.

King C, Dodge M, MacNeil K, Tessier T, Mymryk J, Mehle A J Virol. 2024; 98(5):e0020724.

PMID: 38639487 PMC: 11092356. DOI: 10.1128/jvi.00207-24.


HBO1/KAT7/MYST2 HAT complex regulates human adenovirus replicative cycle.

Kamel H, Shete V, Gadamsetty S, Graves D, Bachus S, Akkerman N Heliyon. 2024; 10(7):e28827.

PMID: 38601626 PMC: 11004756. DOI: 10.1016/j.heliyon.2024.e28827.


ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair.

Bachus S, Akkerman N, Fulham L, Graves D, Helwer R, Rempel J Nucleic Acids Res. 2024; 52(10):5658-5675.

PMID: 38520408 PMC: 11162773. DOI: 10.1093/nar/gkae208.


References
1.
Nevins J . Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell. 1981; 26(2 Pt 2):213-20. DOI: 10.1016/0092-8674(81)90304-4. View

2.
Ricciardi R, Jones R, Cepko C, Sharp P, Roberts B . Expression of early adenovirus genes requires a viral encoded acidic polypeptide. Proc Natl Acad Sci U S A. 1981; 78(10):6121-5. PMC: 348989. DOI: 10.1073/pnas.78.10.6121. View

3.
Nevins J . Induction of the synthesis of a 70,000 dalton mammalian heat shock protein by the adenovirus E1A gene product. Cell. 1982; 29(3):913-9. DOI: 10.1016/0092-8674(82)90453-6. View

4.
Foung S, Sasaki D, Grumet F, Engleman E . Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine. Proc Natl Acad Sci U S A. 1982; 79(23):7484-8. PMC: 347364. DOI: 10.1073/pnas.79.23.7484. View

5.
Virtanen A, Pettersson U . The molecular structure of the 9S mRNA from early region 1A of adenovirus serotype 2. J Mol Biol. 1983; 165(3):496-9. DOI: 10.1016/s0022-2836(83)80215-0. View